{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:44:38Z","timestamp":1788965078632,"version":"build-2803163510"},"reference-count":140,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Chronic Disease"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM) is a chronic metabolic condition marked by insulin resistance, decreased insulin production, and persistent low-grade inflammation. The prevalence of T2DM has increased significantly in recent decades; as a result, it is now regarded as one of the fastest-growing public health concerns worldwide. Long-term micro- and macrovascular problems such as nephropathy, retinopathy, neuropathy, and cardiovascular disease can be caused by poor blood glucose control. Therefore, developing reliable diagnostic indicators for early diagnosis and investigating new treatment targets are critical for addressing the increasing prevalence of T2DM. Several novel diagnostic approaches have been created by targeting endogenous proteins, with fetuin-A being one of the most promising targets. Human fetuin-A, also referred to as alpha-2-Heremans Schmid glycoprotein, is a liver-produced glycoprotein that is abundantly secreted into the bloodstream and seems to be involved in insulin resistance, metabolic syndrome, and inflammation. Clinical studies have shown that circulating fetuin-A levels are closely associated with T2DM and its complications, underscoring its potential as both a biomarker and a therapeutic target. This narrative review provides a detailed overview of the evolving role of fetuin-A in the development of T2DM and its associated complications, as well as its future perspectives.<\/jats:p>","DOI":"10.1177\/20406223251389795","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:14:56Z","timestamp":1762604096000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["The evolving roles of fetuin-A in type 2 diabetes mellitus and its potential clinical implications: a review"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6700-9972","authenticated-orcid":false,"given":"Mohammed","family":"Jemal","sequence":"first","affiliation":[{"name":"Department of Biomedical Science, School of Medicine, Debre Markos University, P.O. Box 269, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuredin Chura","family":"Waritu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temesgen","family":"Baylie","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, School of Medicine, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deresse","family":"Sinamaw","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, School of Medicine, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyew Fenta","family":"Mengistu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, School of Medicine, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enatnesh Essa","family":"Osman","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, School of Medicine, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelagey","family":"Baye","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, School of Medicine, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6178-8335","authenticated-orcid":false,"given":"Bantayehu Addis","family":"Tegegne","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, College of Medicine and Health Sciences, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gashaw Azanaw","family":"Amare","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigale Hibstu","family":"Teffera","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabarak","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Institute of Health, Jimma University, Jimma, Ethiopia"},{"name":"Division of Research and Development, Lovely Professional University, Phagwara, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birhanu","family":"Malede","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baye","family":"Ashenef","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, School of Medicine, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desalegn","family":"Abebaw","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adane","family":"Adugna","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"key":"e_1_3_5_2_2","article-title":"1. Improving care and promoting health in populations: standards of care in diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2023","unstructured":"American Diabetes Association Professional Practice Committee. 1. Improving care and promoting health in populations: standards of care in diabetes\u20142024. Diabetes Care 2023; 47: S11\u2013S19.","journal-title":"Diabetes Care"},{"key":"e_1_3_5_3_2","unstructured":"IDF. Diabetes atlas diabetesatlas.org (2025 accessed 21 August 2025)."},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.945287"},{"key":"e_1_3_5_5_2","author":"Epitope Diagnostics Inc","year":"2012","unstructured":"Epitope Diagnostics Inc. EDI kit insert: H-fetuin ELISA. 2012.","journal-title":"EDI kit insert: H-fetuin ELISA"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.2478\/jbcr-2018-0002"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-018-1110-5"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1515\/tjb-2024-0235"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14365"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001765"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4806.25.09712-5"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2024.10426"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13191662"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05435-1"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.2174\/187221411799015372"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(97)00216-3"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1515\/jbcr-2017-0015"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2851"},{"key":"e_1_3_5_19_2","first-page":"59","article-title":"Posttranslational processing of human alpha 2-HS glycoprotein (human fetuin). Evidence for the production of a phosphorylated single-chain form by hepatoma cells","volume":"226","author":"Jahnen-Dechent W","year":"1994","unstructured":"Jahnen-Dechent W, Trindl A, Godovac-Zimmermann J, et al. Posttranslational processing of human alpha 2-HS glycoprotein (human fetuin). Evidence for the production of a phosphorylated single-chain form by hepatoma cells. Eur J Biochem 1994; 226: 59\u201369.","journal-title":"Eur J Biochem"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.13.4403"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268592"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00089.2018"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90098-6"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0538"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48600-9"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1797-8"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126627"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122033"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0148"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009080820"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-017-1068-9"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kww095"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.5812\/ijhrba.91963"},{"key":"e_1_3_5_34_2","article-title":"1005 Study of visfatin and fetuin-A in type 2 diabetes mellitus in children","volume":"106","author":"Gouda A.","year":"2021","unstructured":"Gouda A. 1005 Study of visfatin and fetuin-A in type 2 diabetes mellitus in children. J Arch Dis Child 2021; 106: A189\u2013A190.","journal-title":"J Arch Dis Child"},{"issue":"2","key":"e_1_3_5_35_2","first-page":"93","article-title":"Serum fetuin-A levels in patients with type 2 diabetes mellitus","volume":"23","author":"Wojtysiak Duma B","year":"2010","unstructured":"Wojtysiak Duma B, Malecha-J\u0229draszek A, Burska A, et al. Serum fetuin-A levels in patients with type 2 diabetes mellitus. Curr Issues Pharm Med Sci 2010; 23(2): 93\u201399.","journal-title":"Curr Issues Pharm Med Sci"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2018.0171"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.3923\/jms.2015.229.234"},{"key":"e_1_3_5_38_2","article-title":"Evaluation of fetuin A, hepassocin, selenoprotien P levels and number of biochemical variables in diabetes mellitus type 2 males\u2019 patients","volume":"3097","author":"Ahmed EH","year":"2024","unstructured":"Ahmed EH, Abdul Wahed AMH. Evaluation of fetuin A, hepassocin, selenoprotien P levels and number of biochemical variables in diabetes mellitus type 2 males\u2019 patients. AIP Conf Proc 2024; 3097: 030029.","journal-title":"AIP Conf Proc"},{"key":"e_1_3_5_39_2","first-page":"58","article-title":"Role of fetuin-A in insulin resistance in type 2 diabetes mellitus","volume":"18","author":"Fatima F","year":"2013","unstructured":"Fatima F, Zuberi N, Noor S, et al. Role of fetuin-A in insulin resistance in type 2 diabetes mellitus. AASH KMDC 2013; 18: 58.","journal-title":"AASH KMDC"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.3892\/br.2014.356"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0372"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.4103\/1110-7782.148140"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019228"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.4103\/ejim.ejim_24_18"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.18231\/j.pjms.2023.097"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.3897\/pharmacia.70.e115795"},{"key":"e_1_3_5_47_2","first-page":"3292","article-title":"Hepatokines fetuin-A and fetuin-B status in obese Saudi patient with diabetes mellitus type 2","volume":"14","author":"Almarashda O","year":"2022","unstructured":"Almarashda O, Abdi S, Yakout S, et al. Hepatokines fetuin-A and fetuin-B status in obese Saudi patient with diabetes mellitus type 2. Am J Transl Res 2022; 14: 3292\u20133302.","journal-title":"Am J Transl Res"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.04.06.dc05-1938"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(00)00237-9"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1992.tb16663.x"},{"key":"e_1_3_5_51_2","first-page":"1445","article-title":"Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level","volume":"7","author":"Srinivas PR","year":"1993","unstructured":"Srinivas PR, Wagner AS, Reddy LV, et al. Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol (Baltimore, MD) 1993; 7: 1445\u20131455.","journal-title":"Mol Endocrinol (Baltimore, MD)"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(97)00737-6"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.139.10.6258"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00237.2013"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009191"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2010.11.003"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(98)00250-1"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.09.071"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.8.2450"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2003.10.013"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3116"},{"key":"e_1_3_5_62_2","article-title":"TLR4\/NF-\u03baB signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE\u2212\/\u2212 mice","volume":"10","author":"Tang YL","year":"2015","unstructured":"Tang YL, Jiang JH, Wang S, et al. TLR4\/NF-\u03baB signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE\u2212\/\u2212 mice. PLoS One 2015; 10: e0123685.","journal-title":"PLoS One"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0360"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7678183"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26052"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-2976-z"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C113.495473"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S499605"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.10.002"},{"key":"e_1_3_5_70_2","article-title":"Exploring fetuin-A as a potential biomarker for type 2 diabetes mellitus: a case-control study","volume":"15","author":"Dhanapriya S","year":"2024","unstructured":"Dhanapriya S, Malarvizhi K, Krishnaprabha K, et al. Exploring fetuin-A as a potential biomarker for type 2 diabetes mellitus: a case-control study. J Cardiovasc Dis Res 2024; 15.","journal-title":"J Cardiovasc Dis Res"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-9-48"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1591"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01439-8"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1541"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2009.10.005"},{"key":"e_1_3_5_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2016.11.006"},{"key":"e_1_3_5_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.01.038"},{"key":"e_1_3_5_78_2","doi-asserted-by":"publisher","DOI":"10.22271\/27069567.2024.v6.i2a.560"},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.21608\/amj.2020.82592"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.108074"},{"key":"e_1_3_5_81_2","first-page":"158","article-title":"Preliminary study of biochemical role of serum fetuin-A level and its gene polymorphism in diabetic patients with microalbuminuria","volume":"5","author":"El-Batch M","year":"2015","unstructured":"El-Batch M, Hamouda H, Hassan S, et al. Preliminary study of biochemical role of serum fetuin-A level and its gene polymorphism in diabetic patients with microalbuminuria. J Diabetes Metab Disord Control 2015; 5: 158\u2013164.","journal-title":"J Diabetes Metab Disord Control"},{"key":"e_1_3_5_82_2","doi-asserted-by":"publisher","DOI":"10.21608\/mjmr.2023.187092.1300"},{"key":"e_1_3_5_83_2","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.893403"},{"key":"e_1_3_5_84_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-017-0750-9"},{"key":"e_1_3_5_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.07.026"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.1186\/s43162-022-00152-6"},{"key":"e_1_3_5_87_2","doi-asserted-by":"publisher","DOI":"10.1177\/1479164113490766"},{"key":"e_1_3_5_88_2","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2015.018"},{"key":"e_1_3_5_89_2","first-page":"991","article-title":"Association of plasma fetuin-A and clinical characteristics in patients with new-onset type 2 diabetes mellitus","volume":"8","author":"Yin L","year":"2015","unstructured":"Yin L, Cai WJ, Zhu LY, et al. Association of plasma fetuin-A and clinical characteristics in patients with new-onset type 2 diabetes mellitus. Int J Clin Exp Med 2015; 8: 991\u2013999.","journal-title":"Int J Clin Exp Med"},{"key":"e_1_3_5_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.03.030"},{"key":"e_1_3_5_91_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0788"},{"key":"e_1_3_5_92_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00172.x"},{"key":"e_1_3_5_93_2","first-page":"9","article-title":"Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in type 2 diabetes","volume":"80","author":"Koluman BU","year":"2013","unstructured":"Koluman BU, Mutluay R, Derici UB, et al. Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in type 2 diabetes. Clin Nephrol 2013; 80: 9\u201316.","journal-title":"Clin Nephrol"},{"key":"e_1_3_5_94_2","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.1921"},{"key":"e_1_3_5_95_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-021-00837-4"},{"key":"e_1_3_5_96_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13898"},{"key":"e_1_3_5_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athplu.2023.09.004"},{"key":"e_1_3_5_98_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13410-024-01324-6"},{"key":"e_1_3_5_99_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01274-w"},{"key":"e_1_3_5_100_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-021-01176-6"},{"key":"e_1_3_5_101_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077118"},{"key":"e_1_3_5_102_2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaa176"},{"key":"e_1_3_5_103_2","article-title":"SUN-156 DNlite-IVD103, a novel urinary test, predicts progressive eGFR decline in type 2 diabetes with microalbuminuria","volume":"5","author":"Chuang L","year":"2020","unstructured":"Chuang L, Lin W, Huang C, et al. SUN-156 DNlite-IVD103, a novel urinary test, predicts progressive eGFR decline in type 2 diabetes with microalbuminuria. Kidney Int Rep 2020; 5: S264.","journal-title":"Kidney Int Rep"},{"key":"e_1_3_5_104_2","doi-asserted-by":"publisher","DOI":"10.1159\/000534514"},{"key":"e_1_3_5_105_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60030363"},{"key":"e_1_3_5_106_2","doi-asserted-by":"publisher","DOI":"10.5603\/ep.96300"},{"key":"e_1_3_5_107_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13410-024-01422-5"},{"key":"e_1_3_5_108_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-024-01533-0"},{"key":"e_1_3_5_109_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312918"},{"key":"e_1_3_5_110_2","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2022-0208"},{"key":"e_1_3_5_111_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.86.16_supplement.P5.329"},{"key":"e_1_3_5_112_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08307-x"},{"key":"e_1_3_5_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.12.135"},{"key":"e_1_3_5_114_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282801"},{"key":"e_1_3_5_115_2","article-title":"Serum fetuin-A and risk of thoracic aortic aneurysms: a two-sample mendelian randomization study","volume":"15","author":"Chen Y","year":"2024","unstructured":"Chen Y, Zhu J, Guo X, et al. Serum fetuin-A and risk of thoracic aortic aneurysms: a two-sample mendelian randomization study. Front Endocrinol (Lausanne) 2024; 15: 1361416.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"e_1_3_5_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156275"},{"key":"e_1_3_5_117_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1505"},{"key":"e_1_3_5_118_2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12382"},{"key":"e_1_3_5_119_2","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S356801"},{"key":"e_1_3_5_120_2","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0000000000000338"},{"key":"e_1_3_5_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2014.09.009"},{"key":"e_1_3_5_122_2","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2019.1631751"},{"key":"e_1_3_5_123_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-021-00738-x"},{"key":"e_1_3_5_124_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2013.09.007"},{"key":"e_1_3_5_125_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1559-4572.2008.00030.x"},{"key":"e_1_3_5_126_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2015.06.001"},{"key":"e_1_3_5_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2012.02.004"},{"key":"e_1_3_5_128_2","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.91695"},{"key":"e_1_3_5_129_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4021623"},{"key":"e_1_3_5_130_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-025-00950-y"},{"key":"e_1_3_5_131_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9040916"},{"key":"e_1_3_5_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167047"},{"key":"e_1_3_5_133_2","first-page":"116","article-title":"Evaluating the effect of combined exercise with Broccoli consumption on fetuin A and B in men with type 2 diabetes","volume":"13","author":"Karimi F","year":"2025","unstructured":"Karimi F, Abednatanzi H, Soheily S, et al. Evaluating the effect of combined exercise with Broccoli consumption on fetuin A and B in men with type 2 diabetes. J Nutr Fasting Health 2025; 13: 116\u2013124.","journal-title":"J Nutr Fasting Health"},{"key":"e_1_3_5_134_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-01156-2"},{"key":"e_1_3_5_135_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-018-0919-x"},{"key":"e_1_3_5_136_2","doi-asserted-by":"publisher","DOI":"10.1556\/2060.106.2019.01"},{"key":"e_1_3_5_137_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-019-0962-2"},{"key":"e_1_3_5_138_2","doi-asserted-by":"publisher","DOI":"10.4103\/tmj.tmj_44_16"},{"key":"e_1_3_5_139_2","doi-asserted-by":"publisher","DOI":"10.1089\/chi.2017.0027"},{"key":"e_1_3_5_140_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(15)60355-1"},{"key":"e_1_3_5_141_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-014-0095-x"}],"container-title":["Therapeutic Advances in Chronic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406223251389795","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20406223251389795","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406223251389795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:20:18Z","timestamp":1777591218000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20406223251389795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":140,"alternative-id":["10.1177\/20406223251389795"],"URL":"https:\/\/doi.org\/10.1177\/20406223251389795","relation":{},"ISSN":["2040-6223","2040-6231"],"issn-type":[{"value":"2040-6223","type":"print"},{"value":"2040-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"article-number":"20406223251389795"}}